A review of other studies has revealed that CRP may not be used as a good prognostic indicator due to its susceptibility to confounding from obesity and metabolic syndrome, both of which are prevalent in this patient population, as we discussed in the introduction section [3]. Here, CRP is linked to obesity due to melanocortin 4 receptor deficiency.